RxDoctor Payments DataLook up a doctor →

Humberto Aguilar, MD

Gastroenterology · Shreveport, LANPI 1366432577

Payments from drug & device makers

$13,100,923in general payments, 2019–2025

Across 3,423 payments — averaging $3827.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$3.8M
  • Boehringer Ingelheim International GmbH$2.8M
  • AbbVie$2.4M
  • Intercept Pharmaceuticals, Inc.$845K
  • E.r. Squibb & Sons, L.L.C.$528K
  • Gilead$450K
  • plus $2.2M from 46 others
$26,411in research payments, 2019–2025

Across 20 payments — averaging $1320.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Celltrion, Inc.$12K
  • Takeda Pharmaceuticals U.S.A., Inc.$11K
  • Eli Lilly$1K
  • AbbVie$1K
  • Novo Nordisk AS$121

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.160$3,791,153
Boehringer Ingelheim International GmbH637$2,801,963
AbbVie(2 entities)741$2,446,711
Intercept Pharmaceuticals, Inc.120$844,570
E.r. Squibb & Sons, L.L.C.29$527,724
Gilead154$449,541
Takeda Pharmaceuticals U.S.A., Inc.230$415,753
Madrigal Pharmaceuticals58$368,339
GSK43$334,760
Ferring Pharmaceuticals AS17$235,867
AstraZeneca9$209,347
Novo Nordisk AS444$90,421
Roche Products Limited37$82,308
Braintree Laboratories, Inc.11$68,717
F. Hoffmann-la Roche AG9$64,734
Lilly USA, LLC64$60,310
Novartis3$50,218
Novo Nordisk35$43,117
Johnson & Johnson108$42,684
Shire North American Group Inc11$40,026
Ipsen Bioscience Inc.14$29,225
Janssen Research & Development, LLC7$23,802
Bausch Health US, LLC3$16,663
Phathom Pharmaceuticals, Inc.26$15,184
Pfizer81$12,161
Intercept Pharma Europe Ltd.4$8,475
Ferring Pharmaceuticals Inc.12$7,663
Eli Lilly22$7,273
UCB Biosciences Inc.1$6,000
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC160$2,151
Bristol Myers Squibb51$930
Janssen Scientific Affairs, LLC5$807
Sanofi25$620
Merck29$450
Daiichi Sankyo Inc.20$349
Ironwood Pharmaceuticals, Inc9$147
Perspectum Diagnostics Ltd1$123
Redhill Biopharma Inc.5$77
Nestle Healthcare Nutrition Inc.4$77
Aimmune Therapeutics, Inc.2$71
Evoke Pharma, Inc.4$63
Amgen3$62
Ipsen Biopharmaceuticals, Inc3$62
Cumberland Pharmaceuticals, Inc.3$47
UCB, Inc.2$35
Ardelyx, Inc.1$34
Sandoz1$20
QOL Medical, LLC1$20
Fresenius Kabi USA, LLC1$20
AMAG Pharmaceuticals, Inc.1$18
Mallinckrodt Hospital Products Inc.1$18
Boehringer Ingelheim1$14

How this compares

$13,100,923 in reported general payments places this provider in the 95th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana

Medicare billing

Part B allowed, 2024
$808,103
Medicare patients
520
Services billed
37,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →